Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National and Kapodistrian University of Athens
With
National Hellenic Research Foundation
Age
50–70
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Postmenopausal women
T-score in the osteopenic range (-1.0 \> T-score \> -2.5) at either the lumbar spine (LS) or femur as measured by dual energy X-ray absorptiometry (DXA)
You may not be if
T-score in the osteoporotic range (T-score \< -2.5) at any site
Patients receiving supplements of calcium and/or vitamin D at that time or during the last 6 months
Patients receiving medications known to positively or negatively affect bone turnover or BMD at that time or during the last 3 years (e.g. antiresorptive agents, oestrogens, systemic corticosteroids), or
Secondary cause of osteoporosis (e.g. alcohol abuse, thyrotoxicosis etc)
Patients who did not attend to their follow-up appointment and consequently had only the baseline measurements
Clareo Health | Design and Development of a Novel Food Supplement for Osteoporosis Based on Gut Microbiome Mechanisms
